This page is intended for UK patients who have been prescribed a medication in the Pathway Portfolio Range

Reporting of Side Effects
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible side effects not listed in the product's package leaflet.
You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard
By reporting side effects, you can help provide more information on the safety of medicines.

I am a UK Patient who has been prescribed Assicco® (glycopyrronium bromide) tablets

By clicking ‘Yes’ you will leave the Pathway Portfolio website and be re-directed to the electronic Medicines Compendium (eMC).
Aspire Pharma is not responsible for the content on external websites.

Yes

I am a UK Patient who has been prescribed Biquelle® XL (quetiapine) prolonged-release tablets

Yes

I am a UK Patient who has been prescribed Combisal® (salmeterol/fluticasone) pressurised metered dose inhaler (pMDI)

Yes

I am a UK Patient who has been prescribed Delofine® XL (felodipine) tablets

By clicking ‘Yes’ you will leave the Pathway Portfolio website and be re-directed to the electronic Medicines Compendium (eMC).
Aspire Pharma is not responsible for the content on external websites.

Yes

I am a UK Patient who has been prescribed Dyzantil®▼(sodium valproate) prolonged-release tablets

Yes

I am a UK Patient who has been prescribed Gatalin® XL (galantamine) prolonged-release capsules

Yes

I am a UK Patient who has been prescribed Neditol® XL (tolterodine) prolonged-release capsules

Yes

I am a UK Patient who has been prescribed Repinex® XL (ropinirole) prolonged-release

Yes

I am a UK Patient who has been prescribed Sevodyne® (buprenorphine) transdermal patches

Yes

I am a UK Patient who has been prescribed Sukkarto® SR (metformin hydrochloride) prolonged-release tablets

By clicking ‘Yes’ you will leave the Pathway Portfolio website and be re-directed to the electronic Medicines Compendium (eMC).
Aspire Pharma is not responsible for the content on external websites.

Yes

I am a UK Patient who has been prescribed Vencarm® XL (venlafaxine) prolonged-release capsules

Yes

MAT-UK-XLP-0049-1 | June 2026

© Copyright 2026 Aspire Pharma Limited | Aspire Pharma Limited is registered in England, company number 06828501